Compass Therapeutics (CMPX) Gains from Investment Securities (2019 - 2025)
Compass Therapeutics recorded quarterly Gains from Investment Securities of $399000.0 in Q4 2025, down 97.68% quarter-over-quarter from $17.2 million in Q3 2025, and up 315.62% year-over-year from $96000.0 in Q4 2024.
Compass Therapeutics' Gains from Investment Securities history runs 7 years deep, the most recent figure standing at $399000.0 for Q4 2025.
- In Q4 2025, Gains from Investment Securities rose 315.62% year-over-year to $399000.0; the TTM figure through Dec 2025 stood at $1.4 million (up 441.57% YoY), while the FY2025 annual figure was $16.4 million, up 164.04% from the prior year.
- Gains from Investment Securities came in at $399000.0 for Q4 2025 at Compass Therapeutics, down from $17.2 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $17.2 million in Q3 2025 to a low of -$1.6 million in Q1 2022.
- A 5-year average of $2.8 million and a median of $607000.0 in 2025 frame the typical range for Gains from Investment Securities.
- Across the five-year window, Gains from Investment Securities slumped 243.09% in 2022 and soared 11133.33% in 2023, its largest moves.
- Compass Therapeutics' Gains from Investment Securities stood at -$33000.0 in 2021, then plunged by 112.12% to -$70000.0 in 2022, then surged by 150.0% to $35000.0 in 2023, then jumped by 174.29% to $96000.0 in 2024, then soared by 315.62% to $399000.0 in 2025.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered $399000.0, $17.2 million, and $4.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Compass Therapeutics | 418.47 Mn | 223.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 399,000.00 |
| Dec 31, 2025 | 399,000.00 |
| Sep 30, 2025 | 17.16 Mn |
| Sep 30, 2025 | 17.16 Mn |
| Jun 30, 2025 | 4.48 Mn |
| Jun 30, 2025 | 4.48 Mn |
| Mar 31, 2025 | 815,000.00 |
| Mar 31, 2025 | 815,000.00 |
| Dec 31, 2024 | 96,000.00 |
| Dec 31, 2024 | 96,000.00 |
| Sep 30, 2024 | 5.75 Mn |
| Sep 30, 2024 | 5.75 Mn |
| Mar 31, 2024 | 136,000.00 |
| Mar 31, 2024 | 136,000.00 |
| Dec 31, 2023 | 35,000.00 |
| Dec 31, 2023 | 35,000.00 |
| Sep 30, 2023 | 7.76 Mn |
| Sep 30, 2023 | 7.76 Mn |
| Jun 30, 2023 | 7.75 Mn |
| Jun 30, 2023 | 7.75 Mn |
| Dec 31, 2022 | -70,000.00 |
| Dec 31, 2022 | -70,000.00 |
| Jun 30, 2022 | 69,000.00 |
| Jun 30, 2022 | 69,000.00 |
| Mar 31, 2022 | -1.57 Mn |
| Mar 31, 2022 | -1.57 Mn |
| Dec 31, 2021 | -33,000.00 |
| Dec 31, 2021 | -33,000.00 |
| Sep 30, 2021 | 1.65 Mn |
| Sep 30, 2021 | 1.65 Mn |
| Mar 31, 2021 | 1.10 Mn |
| Mar 31, 2021 | 1.10 Mn |
| Dec 31, 2020 | 2.16 Mn |
| Dec 31, 2020 | 2.16 Mn |
| Sep 30, 2020 | 1.63 Mn |
| Sep 30, 2020 | 1.63 Mn |
| Jun 30, 2020 | 2.90 Mn |
| Jun 30, 2020 | 2.90 Mn |
| Mar 31, 2020 | 34,000.00 |
| Mar 31, 2020 | 34,000.00 |
| Sep 30, 2019 | -5,000.00 |
| Sep 30, 2019 | -5,000.00 |
| Jun 30, 2019 | 82,000.00 |
| Jun 30, 2019 | 82,000.00 |